Intermittent Liposomal Amphotericin B Primary Prophylaxis

NCT00451711 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Liposomal amphotericin B

Sponsor

Bayside Health

Collaborators

[object Object]